Page last updated: 2024-10-25

eflornithine and Hyperglycemia

eflornithine has been researched along with Hyperglycemia in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research Excerpts

ExcerptRelevanceReference
"Though hyperglycemia has been considered as a fuel for growth of cancer cells, pathways leading to this condition are still under investigation."1.62Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase. ( Capellen, CC; Casero, RA; Chandra, S; Dunworth, M; Morwitzer, MJ; Ortega-Rodas, J; Tofilau, HMN, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Capellen, CC1
Ortega-Rodas, J1
Morwitzer, MJ1
Tofilau, HMN1
Dunworth, M1
Casero, RA1
Chandra, S1
Hostetter, TH1

Other Studies

2 other studies available for eflornithine and Hyperglycemia

ArticleYear
Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase.
    Breast cancer research and treatment, 2021, Volume: 190, Issue:2

    Topics: Breast Neoplasms; Eflornithine; Female; Humans; Hyperglycemia; Ornithine Decarboxylase; Ornithine De

2021
Hypertrophy and hyperfunction of the diabetic kidney.
    The Journal of clinical investigation, 2001, Volume: 107, Issue:2

    Topics: Animals; Diabetic Nephropathies; Eflornithine; Enzyme Inhibitors; Glomerular Filtration Rate; Humans

2001